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ABSTRACT 
 
 
 
Background: Type 2 diabetes mellitus (Type 2 DM) is one of the major causes of 
morbidity and mortality worldwide. Morbidity and mortality due to diabetes are 
associated with the development of various microvascular complications (retinopathy, 
nephropathy, and neuropathy) and macrovascular complications (coronary heart disease, 
stroke, and peripheral vascular disease). This study aimed to examine the determinants 
of biopsychosocial macro and microvascular complications in patients with type 2 DM 
at Dr. Moewardi Surakarta. 
Subjects and Method: This was an analytic observational with a case-control design. 
The study was conducted at Dr. Moewardi, Surakarta, Central Java, from January to 
March 2018. A sample of 150 Type 2 DM cases with complication and 75 Type 2 DM 
cases without complication was selected for this study by fixed disease sampling. The 
dependent variables were macro and microvascular complications. The independent 
variables were body mass index (BMI), blood pressure, quality of life, depression, 
duration of disease, physical activity, diet, medication adherence, health financing, and 
routine blood sample. Clinical data were taken from medical record. The data of other 
variables were collected by a set of pre-tested questionnaire. Logistic regression was 
employed for data analysis. 
Results: The risk of macro and microvascular complications in type 2 DM patients 
increased with high BMI (OR= 19.88; 95% CI= 5.93 to 66.68; p= <0.001), poor quality 
of life (OR= 3.76; 95% CI= 1.28 to 11.00; p= 0.015), depression (OR= 12.48; 95% CI= 
2.99 to 52.05; p= 0.001), longer duration of disease (OR= 3.41; 95% CI= 1.16 to 10.01; 
p= 0.025), lack of physical activity (OR= 7.70; 95% CI= 2.51 to 23.62; p= <0.001), 
poor diet (OR= 4.42; 95% CI= 1.52 to 12.80; p= 0.006), poor medication adherence 
(OR= 4.73; 95% CI= 1.62 to 13.78; p= 0.004), and irregular blood sample control (OR= 
4.07; 95% CI= 1.40 to 11.83; p= 0.010). 
Conclusion: The risk of macro and microvascular complications in patients with type 2 
DM is determined by BMI, quality of life, depression, duration of disease, physical 
activity, diet, medication adherence, and blood sample control. 
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